SG Meditech Pte Ltd is a Singapore-based medical device company that has spent the past 10 years in research and development in the field of cord blood collection.
The Challenge
Lack of innovation in cord blood collection devices has limited the amount of stem cells that can be collected and this has been the main challenge faced by transplant physicians . This limitation in stem cell number count is further exacerbated by the practice of delayed cord clamping .
1,2
3,4
Our Mission
To revolutionize umbilical cord blood collection by increasing stem cell yields for better therapeutic outcomes.
References
1 Barker, J. N. et al. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105(3), 1343-1347.
2 Laughlin, M. J. et al. (2001). Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med, 344, 1815-1822.
3 Allan, D. S. et al. (2016). Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking. Transfusion, 56, 662–665.
4 WHO. Guideline: Delayed umbilical cord clamping for improved maternal and infant health and nutrition outcomes. Geneva, World Health Organization; 2014 (http://www.who.int/nutrition/publications/guidelines/cord_clamping/en/)